Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer.
about
The paradox role of caspase cascade in ionizing radiation therapyConstitutive activation of epidermal growth factor receptor promotes tumorigenesis of Cr(VI)-transformed cells through decreased reactive oxygen species and apoptosis resistance developmentIdentifying kinase dependency in cancer cells by integrating high-throughput drug screening and kinase inhibition dataSIFORM: shared informative factor models for integration of multi-platform bioinformatic data.Additive effects of cherlerythrine chloride combination with erlotinib in human non-small cell lung cancer cells.microRNA-664 enhances proliferation, migration and invasion of lung cancer cellsSevoflurane postconditioning protects rat hearts against ischemia-reperfusion injury via the activation of PI3K/AKT/mTOR signalingThe mTOR signaling pathway as a treatment target for intracranial neoplasmsAMP-activated protein kinase deficiency rescues paraquat-induced cardiac contractile dysfunction through an autophagy-dependent mechanismDifferential Effects of Tyrosine Kinase Inhibitors on Normal and Oncogenic EGFR Signaling and Downstream EffectorsGalectin-1 is overexpressed in CD133+ human lung adenocarcinoma cells and promotes their growth and invasiveness.IL-24 inhibits lung cancer cell migration and invasion by disrupting the SDF-1/CXCR4 signaling axisNRSN2 promotes non-small cell lung cancer cell growth through PI3K/Akt/mTOR pathwayBrown Pine Leaf Extract and Its Active Component Trans-Communic Acid Inhibit UVB-Induced MMP-1 Expression by Targeting PI3KSuppression of MAPK Signaling and Reversal of mTOR-Dependent MDR1-Associated Multidrug Resistance by 21α-Methylmelianodiol in Lung Cancer CellsNon-small cell lung cancer is characterized by dramatic changes in phospholipid profiles.Knockdown of Aurora-B inhibits the growth of non-small cell lung cancer A549 cells.Comparison of next generation sequencing, SNaPshot assay and real-time polymerase chain reaction for lung adenocarcinoma EGFR mutation assessment.Enhanced Anticancer Activity of PF-04691502, a Dual PI3K/mTOR Inhibitor, in Combination With VEGF siRNA Against Non-small-cell Lung CancerExosomal miRs in Lung Cancer: A Mathematical Model.Inhibition of the growth of non-small cell lung cancer by miRNA-1271Effects of PI3K inhibitor NVP-BKM120 on overcoming drug resistance and eliminating cancer stem cells in human breast cancer cellsUnique roles of Akt1 and Akt2 in IGF-IR mediated lung tumorigenesis.The Clinical Significance of the Insulin-Like Growth Factor-1 Receptor Polymorphism in Non-Small-Cell Lung Cancer with Epidermal Growth Factor Receptor MutationCabazitaxel-induced autophagy via the PI3K/Akt/mTOR pathway contributes to A549 cell death.CGP57380 enhances efficacy of RAD001 in non-small cell lung cancer through abrogating mTOR inhibition-induced phosphorylation of eIF4E and activating mitochondrial apoptotic pathway.High Expression of PHGDH Predicts Poor Prognosis in Non-Small Cell Lung CancerHDAC10 promotes lung cancer proliferation via AKT phosphorylation.Superior efficacy of co-treatment with the dual PI3K/mTOR inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A against NSCLCRole of Autophagy and Apoptosis in Non-Small-Cell Lung Cancer.Noninvasive Bioluminescence Imaging of AKT Kinase Activity in Subcutaneous and Orthotopic NSCLC Xenografts: Correlation of AKT Activity with Tumor Growth Kinetics.Radiation-induced signaling pathways that promote cancer cell survival (review).Heat-shock protein 90 (Hsp90) as anticancer target for drug discovery: an ample computational perspective.New Treatment Opportunities in Phosphatase and Tensin Homolog (PTEN)-Deficient Tumors: Focus on PTEN/Focal Adhesion Kinase Pathway.PTEN and PI3K/AKT in non-small-cell lung cancer.Targeting therapeutic liabilities engendered by PIK3R1 mutations for cancer treatment.Nrf2 but not autophagy inhibition is associated with the survival of wild-type epidermal growth factor receptor non-small cell lung cancer cells.ANGPTL4 Correlates with NSCLC Progression and Regulates Epithelial-Mesenchymal Transition via ERK Pathway.Inhibition of lung cancer in diethylnitrosamine-induced mice by Rhizoma paridis saponins.Interleukin-22 promotes lung cancer cell proliferation and migration via the IL-22R1/STAT3 and IL-22R1/AKT signaling pathways.
P2860
Q28079723-D3E3B84C-ADD0-4EDB-B87B-EF03D419E900Q28386290-E28D0F97-90C1-4096-8025-7EA006C57A58Q30982375-C7555BD5-21ED-4B44-B97F-8C3F7F370E14Q31112697-8327E3E3-3566-4A51-AB26-F2DB719F5999Q33554429-5FF0CD40-0A2A-4847-A142-DBE3920EE251Q33745073-08AC59E6-98C7-404A-B4C3-5B5B24094379Q34628699-6AB815BC-EC2C-4E36-AEC4-78BE9AB68469Q34886859-8E52576D-2079-473C-9700-89E9DAD150CEQ35102608-CDFBC7D1-C96B-4A1B-9CC7-3DCD2C3B6077Q35434274-41DDBB84-2945-49B9-BC44-4401605D2087Q35550185-B3A395C6-7D7B-47F2-9CB2-022BF2A99B59Q35578377-30F724A0-C5A4-42AC-952A-469EDFC93FA7Q35632096-BEDBC80C-7126-4528-A802-F30BBA6E7DD7Q35661253-9D965CDD-10BB-4680-8738-66516D1315ABQ35670917-6F211D75-F5C0-44C8-A33D-D8B101561F97Q35855382-A480B0A7-8EB7-4C30-8C96-4B7CEEEF2599Q35944474-3716E653-4C04-44B2-8AE8-773F8E4BDEF7Q36027021-51932CE9-5746-452C-B5C9-3A0603D8370FQ36192506-CEE4FB1B-E028-46F4-BE62-4077A76E10F4Q36230579-10E6CD46-E4C9-47FD-B66B-25BB60172DC8Q36309509-2205F943-DC7A-4A28-B2D5-7785CE6C1098Q36485168-2E3E938B-173D-418D-A2E8-6A65CDA21ABFQ36772120-8934AE8F-76D4-4B29-AB37-273A5692258BQ36939336-5ED688B6-731D-47E6-B7E1-BE57536F41EDQ37297473-B51A5D78-64BA-49D9-9345-F8583868009FQ37317400-398A2399-DED4-4C1B-A583-068A7110DEAAQ37482658-CFDB0FE8-9EAD-42C1-A4DE-89DAA362FAF3Q37644872-6B0EB7F9-15CA-4225-9FED-04D9E3204F34Q37645002-98426743-8EE7-4F1C-9A4C-3997742E83BAQ37690890-C8F6CB7E-3676-4AF1-8F04-FE060AC63B95Q37736706-5F9FE85F-EF3F-4C17-9762-450C8B4BAB8BQ38244964-CAAE6DE1-13C2-4E37-83AD-83644B74AA62Q38469746-79B7CFB6-48A5-4E4F-9CF3-A26586EF5DE1Q38604713-3AEBE27B-F5DA-42F2-A25F-B1291530E673Q38629644-0A82A4E2-010B-4911-9CDE-126319CC5E10Q38710557-0B73DA41-8DC6-415E-BDBB-7C1CA0BD266BQ38745806-BCF2AA49-9ADB-4EBE-8431-969586D45351Q38771817-26C04D09-EADF-47F7-A7F8-390789C1DCDDQ38780929-311BB528-C072-4192-934D-39D693AB602EQ38785873-E5808000-1950-4E23-B7CE-63B4256F60DF
P2860
Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer.
@en
type
label
Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer.
@en
prefLabel
Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer.
@en
P2093
P1476
Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer.
@en
P2093
Mara A Bonelli
Pier Giorgio Petronini
Roberta R Alfieri
P304
P356
10.1016/J.BCP.2014.05.011
P407
P577
2014-05-24T00:00:00Z